Skip to main content

Advertisement

Table 1 Participant’s characteristics in the groups under study

From: Effect of valerian on cognitive disorders and electroencephalography in hemodialysis patients: a randomized, cross over, double-blind clinical trial

Index Group
Aa B
Number Percent Number Percent
Sex Female 10 52.6 9 45
Mal 9 47.4 11 55
Body Mass Index > 18.5 1 5.3 3 15
18.5–24.9 12 63.2 12 60
25–29.9 6 31.6 5 25
Education level illiterate 6 31.6 7 35
Elementary 9 47.4 6 30
Diploma or higher 4 21.1 7 35
Income Low 4 21.1 6 30
Average 14 73.7 14 70
Good 1 5.2
Dialysis causes DM 7 36.8 5 25
HTN 4 21.1 4 20
DM,HTN 4 21.1 8 40
Other 4 21.1 3 15
HD + 5 26.3 5 25.0
14 73.7 15 75.0
RLL + 13 68.4 9 45/0
6 31.6 11 55.0
Number of cups of tea 0 2 10
1 5 26.3 5 25
2 13 68.4 10 50
≥3 1 5.3 3 15
  1. aThe group A took valerian capsules in the first therapeutic period of one month and placebo in the second therapeutic period of one month, and vice versa in group B